Cargando…

Clinical Features and Surgical Treatment of Primary Pulmonary Lymphoma: A Retrospective Study

BACKGROUND: Primary pulmonary lymphoma (PPL) is a rare clonal lymphoproliferative lung disease. The present study analyzes the clinical features, imaging data, pathologic characteristics, treatment, and prognosis of PPL patients, with the aim to discuss the appropriate diagnosis and therapy of PPL p...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Hui, Zhou, Yaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850835/
https://www.ncbi.nlm.nih.gov/pubmed/35186728
http://dx.doi.org/10.3389/fonc.2022.779395
_version_ 1784652687342567424
author Shen, Hui
Zhou, Yaodong
author_facet Shen, Hui
Zhou, Yaodong
author_sort Shen, Hui
collection PubMed
description BACKGROUND: Primary pulmonary lymphoma (PPL) is a rare clonal lymphoproliferative lung disease. The present study analyzes the clinical features, imaging data, pathologic characteristics, treatment, and prognosis of PPL patients, with the aim to discuss the appropriate diagnosis and therapy of PPL patients in thoracic surgery. METHODS: We performed a retrospective analysis on 36 patients with PPL confirmed by postoperative pathology between 2006 and 2020. We divided the patients into low-stage (IE) and high-stage (IIE) groups using modified Ann Arbor staging. The clinical manifestations, imaging findings, treatment modalities, and outcomes were evaluated. RESULTS: The female to male ratio was 1.57:1 and the median age was 55 (31–69) years old. The majority of the patients had stage IE disease (75%; 27 of 36) and 9 patients had stage IIE disease. Patients with advancing stage were more likely to have respiratory symptoms. The imaging findings presented solid nodule or mass, pneumonia-like consolidative pattern, ground-glass opacity, and mixed pattern. There were 31 cases of mucosa-associated lymphoid tissue lymphoma (MALT), 2 diffuse large B-cell lymphoma (DLBCL), 2 nodular sclerosing Hodgkin’s lymphoma, and 1 marginal zone B-cell lymphoma. Two patients were diagnosed with PPL and non-small cell lung cancer (NSCLC) synchronously (one AIS and MIS and one lung adenocarcinoma). All the patients received surgery. Nine patients received adjuvant therapy after surgery (five radiotherapy, two chemotherapy, and two chemoradiotherapy). Thirty-four patients had a median follow-up time of 31 months (follow-up range: 7–152 months). Of the 34 patients, 1 patient died of liver metastases and 1 patient died of intestinal metastases. CONCLUSIONS: Our retrospective analysis suggested that most PPLs were indolent and had favorable prognosis, but the discrimination of PPL with other lung diseases was difficult. Preoperative biopsy and intraoperative frozen section examination might help in the surgical choice. Limited lung resection was enough for peripherally localized PPL.
format Online
Article
Text
id pubmed-8850835
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88508352022-02-18 Clinical Features and Surgical Treatment of Primary Pulmonary Lymphoma: A Retrospective Study Shen, Hui Zhou, Yaodong Front Oncol Oncology BACKGROUND: Primary pulmonary lymphoma (PPL) is a rare clonal lymphoproliferative lung disease. The present study analyzes the clinical features, imaging data, pathologic characteristics, treatment, and prognosis of PPL patients, with the aim to discuss the appropriate diagnosis and therapy of PPL patients in thoracic surgery. METHODS: We performed a retrospective analysis on 36 patients with PPL confirmed by postoperative pathology between 2006 and 2020. We divided the patients into low-stage (IE) and high-stage (IIE) groups using modified Ann Arbor staging. The clinical manifestations, imaging findings, treatment modalities, and outcomes were evaluated. RESULTS: The female to male ratio was 1.57:1 and the median age was 55 (31–69) years old. The majority of the patients had stage IE disease (75%; 27 of 36) and 9 patients had stage IIE disease. Patients with advancing stage were more likely to have respiratory symptoms. The imaging findings presented solid nodule or mass, pneumonia-like consolidative pattern, ground-glass opacity, and mixed pattern. There were 31 cases of mucosa-associated lymphoid tissue lymphoma (MALT), 2 diffuse large B-cell lymphoma (DLBCL), 2 nodular sclerosing Hodgkin’s lymphoma, and 1 marginal zone B-cell lymphoma. Two patients were diagnosed with PPL and non-small cell lung cancer (NSCLC) synchronously (one AIS and MIS and one lung adenocarcinoma). All the patients received surgery. Nine patients received adjuvant therapy after surgery (five radiotherapy, two chemotherapy, and two chemoradiotherapy). Thirty-four patients had a median follow-up time of 31 months (follow-up range: 7–152 months). Of the 34 patients, 1 patient died of liver metastases and 1 patient died of intestinal metastases. CONCLUSIONS: Our retrospective analysis suggested that most PPLs were indolent and had favorable prognosis, but the discrimination of PPL with other lung diseases was difficult. Preoperative biopsy and intraoperative frozen section examination might help in the surgical choice. Limited lung resection was enough for peripherally localized PPL. Frontiers Media S.A. 2022-02-03 /pmc/articles/PMC8850835/ /pubmed/35186728 http://dx.doi.org/10.3389/fonc.2022.779395 Text en Copyright © 2022 Shen and Zhou https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Shen, Hui
Zhou, Yaodong
Clinical Features and Surgical Treatment of Primary Pulmonary Lymphoma: A Retrospective Study
title Clinical Features and Surgical Treatment of Primary Pulmonary Lymphoma: A Retrospective Study
title_full Clinical Features and Surgical Treatment of Primary Pulmonary Lymphoma: A Retrospective Study
title_fullStr Clinical Features and Surgical Treatment of Primary Pulmonary Lymphoma: A Retrospective Study
title_full_unstemmed Clinical Features and Surgical Treatment of Primary Pulmonary Lymphoma: A Retrospective Study
title_short Clinical Features and Surgical Treatment of Primary Pulmonary Lymphoma: A Retrospective Study
title_sort clinical features and surgical treatment of primary pulmonary lymphoma: a retrospective study
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850835/
https://www.ncbi.nlm.nih.gov/pubmed/35186728
http://dx.doi.org/10.3389/fonc.2022.779395
work_keys_str_mv AT shenhui clinicalfeaturesandsurgicaltreatmentofprimarypulmonarylymphomaaretrospectivestudy
AT zhouyaodong clinicalfeaturesandsurgicaltreatmentofprimarypulmonarylymphomaaretrospectivestudy